India
Gastroenterology · 4 min read

Refractory celiac disease

Learn about Refractory celiac disease, its reported features, relevant specialists, and questions to discuss at a medical consultation.

Also known as: Refractory CD; Refractory sprue

Compiled from public sources
Text selected and arranged from Orphanet. It describes the condition as those sources do; it has not been rewritten for India.
01 Oct 2026
Not medically reviewed
No registered doctor has reviewed this page. Use it to decide who to see and what to ask — not to diagnose or treat.
—
This is not medical advice. If symptoms are severe, sudden or getting worse, call 112 (or 108 for an ambulance) or go to the nearest emergency department.

The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis. Ask the treating doctor about these.

What it is

From: Orphanet

Refractory celiac disease is a rare intestinal disease characterized by persistent or recurrent symptoms and signs of confirmed celiac disease despite a long-term, strict, gluten-free diet, in the absence of other causes of villous atrophy or malignant complications and with or without presence of increased abnormal intraepitelial lymphocytes.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Autoimmune antibody positivity · Very frequent (99-80%)
The presence of an antibody in the blood circulation that is directed against the organism's own cells or tissues.
Increased proportion of HLA DR+ T cells · Very frequent (99-80%)
Abnormal increase of the activated HLA-DR+ CD4+ T cell subpopulation, measured as percentage of total CD4+ T cells in the blood, compared to a reference range for a given sex and age-group.
Villous atrophy · Obligate (100%)
The enteric villi are atrophic or absent.
Abdominal pain · Frequent (79-30%)
An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) and perceived to originate in the abdomen.
Chronic diarrhea · Frequent (79-30%)
The presence of chronic diarrhea, which is usually taken to mean diarrhea that has persisted for over 4 weeks.
Elevated circulating hepatic transaminase concentration · Frequent (79-30%)
Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage.
Hypoalbuminemia · Frequent (79-30%)
The concentration of albumin in the blood circulation is below the lower limit of normal.
Hypoproteinemia · Frequent (79-30%)
A decreased concentration of protein in the blood.
Inflammatory abnormality of the skin · Frequent (79-30%)
The presence of inflammation of the skin. That is, an abnormality of the skin resulting from the local accumulation of fluid, plasma proteins, and leukocytes.
Jejunitis · Frequent (79-30%)
Inflammation of the lining of the middle section of the small intestine.
Malabsorption · Frequent (79-30%)
Impaired ability to absorb one or more nutrients from the intestine.
Malnutrition · Frequent (79-30%)
A deficiency in the intake of energy and nutrients.
Microcytic anemia · Frequent (79-30%)
A kind of anemia in which the volume of the red blood cells is reduced.
Weight loss · Frequent (79-30%)
Reduction of total body weight.

Other findings in the same source

From: Orphanet

Additional reported features include Iron deficiency anemia (Frequent (79-30%)); Abnormal spleen physiology (Occasional (29-5%)); Abnormality of the nervous system (Occasional (29-5%)); Arthralgia (Occasional (29-5%)); Elevated alkaline phosphatase of bone origin (Occasional (29-5%)); Hypocalcemia (Occasional (29-5%)); Hypomagnesemia (Occasional (29-5%)); Hypophosphatemia (Occasional (29-5%)); Low serum calcitriol (Occasional (29-5%)); Osteoporosis (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

All ages

Inheritance in the source

From: Orphanet

Not applicable

Frequency and the population described

From: Orphanet

Point prevalence: Unknown; Worldwide; Class only.

Which doctor should you see?

The suggested department for discussing Refractory celiac disease is Gastroenterology, with a gastroenterologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

  • Which digestive symptoms or nutritional changes matter most?
  • What question would an endoscopy, scan or laboratory test answer if one is proposed?
  • How should persistent pain, bleeding or difficulty eating be followed up?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Refractory celiac disease. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.

Find a doctor for Refractory celiac disease

This condition is usually assessed by a gastroenterologist. Every profile shows the doctor’s registration and what has been checked.

All gastroenterology conditions →

Sources

Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.

General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-2021.